Storm of 'awakened' transposons may cause brain-cell pathologies in ALS, other illnesses

September 6, 2012

A team of neuroscientists and informatics experts at Cold Spring Harbor Laboratory (CSHL) reports important progress in an effort to understand the relationship between transposons – sequences of DNA that can jump around within the genome, potentially causing great damage – and mechanisms involved in serious neurodegenerative disorders including ALS (amyotrophic lateral sclerosis, also known as Lou Gehrig's disease), FTLD (frontotemporal lobar degeneration) and Alzheimer's disease.

A close analysis of previously unanalyzed has led CSHL Associate Professor Joshua Dubnau, Ph.D., and colleagues to discover a signature of disease that may help explain these and other neural pathologies. As reported by the team September 6 in the journal , this signature leads them to hypothesize that dormant transposons awaken in the genome, setting off the equivalent of a transposon storm in some , capable of causing cell death.

Transposons – often called transposable elements, or TEs, by scientists – are understood collectively to occupy a large fraction (~40%) of the genetic material of , including humans. Most TEs are genomic fossils, effectively inactive. A minority of TEs capable of activation are ordinarily suppressed by a variety of mechanisms that have evolved along with life over of time to prevent sudden rearrangements (i.e., mutations) of the .

Dubnau's team, in collaboration with the team of CSHL Assistant Professor Molly Hammell, Ph.D., a bioinformatics expert and co-senior author of the new paper, were intrigued by recent research indicating that some transposable elements are active in brain cells during neurogenesis, the process in which new neurons are born, as well as during normal brain development.

They postulate that mobile chunks of DNA somehow evade the mechanisms that normally restrain them, in certain neuropathologies. For this reason they decided to comb vast datasets for evidence of a particular kind of interaction: the binding of a protein called TDP-43 to RNA "messages" copied from portions of the genome occupied by TEs.

TDP-43 is a versatile protein, known to bind to both DNA and RNA in cells. Accumulations of proteins and RNAs that prominently include TDP-43 are known to have a causal role in ALS pathology. TDP-43 is also known to be associated with FTLD, a condition in which frontal and temporal lobes of the brain atrophy. "Accumulations of TDP-43 in what we call 'inclusion bodies' within the cell's cytoplasm is a shared pathological hallmark in a broad spectrum of neurodegenerative disorders including in ALS and FTLD," Dubnau says.

The CSHL scientists noted that TDP-43 was bound to transposon-derived RNAs across three independent, publicly archived genomic datasets from rat, mouse and human samples. Separate research revealed that this association of the binding protein and TE-derived transcripts was less common in the brain cells of FTLD patients, relative to healthy people. They also observed in two different mouse models with TDP-43 dysfunction that the number of observed TE-derived RNA messages was significantly elevated.

"Putting all these observations together," Dubnau says, "we are now suggesting that TDP-43 normally functions to silence or repress the expression of potentially harmful transposons. When TDP-43 function is compromised, these mobile elements become overexpressed. And this, we hypothesize, may contribute to toxic effects underlying pathologies we see in ALS, FTLD, and perhaps other neurodegenerative conditions."

Current research by the CSHL team aims to flesh out these relationships, and particularly to determine, in Dubnau's words, "whether the unleashing of transposons is a cause or a consequence of the neurodegeneration that we know to be associated with TDP-43 accumulation, in these devastating illnesses."

Explore further: Potential new drug target in Lou Gehrig's disease

More information: "Transposable Elements in TDP-43-mediated Neurodegenerative Disorders" appears September 6, 2012 in PloS One. The authors are: W. Li, Y. Lin, L. Prazak, M. Hammell and J. Dubnau. www.plosone.org/article/info%3 … journal.pone.0044099

Related Stories

Potential new drug target in Lou Gehrig's disease

November 14, 2011
Two proteins conspire to promote a lethal neurological disease, according to a study published online this week in the Journal of Experimental Medicine.

Disease progression halted in rat model of Lou Gehrig's disease

December 12, 2011
Amyotrophic lateral sclerosis (ALS; also known as Lou Gehrig's disease) is an incurable adult neurodegenerative disorder that progresses to paralysis and death. Genetic mutations are the cause of disease in 5% of patients ...

Recommended for you

Distinct human mutations can alter the effect of medicine

December 18, 2017
Every person has a unique DNA sequence. Now, researchers from the University of Copenhagen and the MRC Laboratory of Molecular Biology in Cambridge have tried to quantify what these differences in the genome mean in the context ...

Association found between abnormal cerebral connectivity and variability in the PPARG gene in developing preterm infants

December 12, 2017
(Medical Xpress)—A team of researchers with King's College London and the National Institute for Health Research Biomedical Research Centre, both in the U.K., has found what they describe as a strong association between ...

Large genetic study links tendency to undervalue future rewards with ADHD, obesity

December 11, 2017
Researchers at University of California San Diego School of Medicine have found a genetic signature for delay discounting—the tendency to undervalue future rewards—that overlaps with attention-deficit/hyperactivity disorder ...

Gene variants identified that may influence sexual orientation in men and boys

December 8, 2017
(Medical Xpress)—A large team of researchers from several institutions in the U.S. and one each from Australia and the U.K. has found two gene variants that appear to be more prevalent in gay men than straight men, adding ...

Disease caused by reduction of most abundant cellular protein identified

December 8, 2017
An international team of scientists and doctors has identified a new disease that results in low levels of a common protein found inside our cells.

Study finds genetic mutation causes 'vicious cycle' in most common form of amyotrophic lateral sclerosis

December 8, 2017
University of Michigan-led research brings scientists one step closer to understanding the development of neurodegenerative disorders such as ALS.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.